Renata Ltd.
RENATA · DSE · Pharmaceuticals
About the company
Renata Limited is one of Bangladesh's top pharmaceutical and animal health companies, manufacturing a wide range of human medicines and veterinary products. The company exports to multiple countries and operates several WHO-GMP-accredited manufacturing plants. It was formerly a subsidiary of Pfizer Inc. before being acquired by local investors.
| Exchange | DSE |
| Ticker | RENATA |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $420.00M |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (DSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Dhaka Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Bangladesh
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.